782 related articles for article (PubMed ID: 26189784)
1. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
2. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
3. Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy.
Gao H; Qian J; Yang Z; Pang Z; Xi Z; Cao S; Wang Y; Pan S; Zhang S; Wang W; Jiang X; Zhang Q
Biomaterials; 2012 Sep; 33(26):6264-72. PubMed ID: 22683171
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
[TBL] [Abstract][Full Text] [Related]
5. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Stoltenburg R; Reinemann C; Strehlitz B
Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
[TBL] [Abstract][Full Text] [Related]
6. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
7. Evolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imaging.
Wu Q; Wu L; Wang Y; Zhu Z; Song Y; Tan Y; Wang XF; Li J; Kang D; Yang CJ
Biosens Bioelectron; 2016 Jun; 80():1-8. PubMed ID: 26802746
[TBL] [Abstract][Full Text] [Related]
8. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-aptamer conjugates for cancer cell targeting and detection.
Estévez MC; Huang YF; Kang H; O'Donoghue MB; Bamrungsap S; Yan J; Chen X; Tan W
Methods Mol Biol; 2010; 624():235-48. PubMed ID: 20217600
[TBL] [Abstract][Full Text] [Related]
10. Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.
Hays EM; Duan W; Shigdar S
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29189740
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell targeting using multiple aptamers conjugated on nanorods.
Huang YF; Chang HT; Tan W
Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
[TBL] [Abstract][Full Text] [Related]
12. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
13. Comparison of whole-cell SELEX methods for the identification of Staphylococcus aureus-specific DNA aptamers.
Moon J; Kim G; Park SB; Lim J; Mo C
Sensors (Basel); 2015 Apr; 15(4):8884-97. PubMed ID: 25884791
[TBL] [Abstract][Full Text] [Related]
14. The efficient cell-SELEX strategy, Icell-SELEX, using isogenic cell lines for selection and counter-selection to generate RNA aptamers to cell surface proteins.
Takahashi M; Sakota E; Nakamura Y
Biochimie; 2016 Dec; 131():77-84. PubMed ID: 27693080
[TBL] [Abstract][Full Text] [Related]
15. X-Aptamer Selection and Validation.
Lokesh GL; Wang H; Lam CH; Thiviyanathan V; Ward N; Gorenstein DG; Volk DE
Methods Mol Biol; 2017; 1632():151-174. PubMed ID: 28730438
[TBL] [Abstract][Full Text] [Related]
16. Aptamers: current challenges and future prospects.
Rozenblum GT; Lopez VG; Vitullo AD; Radrizzani M
Expert Opin Drug Discov; 2016; 11(2):127-35. PubMed ID: 26630462
[TBL] [Abstract][Full Text] [Related]
17. Identification of liver cancer-specific aptamers using whole live cells.
Shangguan D; Meng L; Cao ZC; Xiao Z; Fang X; Li Y; Cardona D; Witek RP; Liu C; Tan W
Anal Chem; 2008 Feb; 80(3):721-8. PubMed ID: 18177018
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide aptamers for glioma targeting: an update.
Camorani S; Cerchia L
Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
[TBL] [Abstract][Full Text] [Related]
19. Selection and Application of Aptamers and Intramers.
Avci-Adali M
Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of DNA aptamers with binding selectivity to Campylobacter jejuni using whole-cell SELEX.
Dwivedi HP; Smiley RD; Jaykus LA
Appl Microbiol Biotechnol; 2010 Aug; 87(6):2323-34. PubMed ID: 20582587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]